Guardant Health (GH) News Today

Guardant Health logo
$146.36 +0.77 (+0.53%)
As of 01:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Why Is Guardant Health Up Today?

Guardant Health, Inc. (NASDAQ: GH) faces mixed near-term signals: a new cancer-monitoring product and bullish analyst coverage may support the shares, while valuation concerns and an insider sale could weigh on sentiment.

  • Positive Sentiment: Guardant Health launched Guardant Reveal Ultra in U.S. clinics. The solid-tumor molecular residual disease platform is designed to detect cancer at levels as low as one part per million, adding a new offering that could broaden the company’s testing opportunity. Guardant Health launches Reveal Ultra
  • Positive Sentiment: Stephens reaffirmed its “overweight” rating and set a $210 price target, signaling substantial potential upside from the price cited in the report. Stephens ratings
  • Positive Sentiment: A recent report highlighted raised guidance, which may reinforce expectations for the company’s growth, though the provided headline did not include the updated figures. Report on Guardant Health’s raised guidance
  • Negative Sentiment: Another recent analysis questioned whether GH is richly valued after its strong run, a concern that could limit investor appetite despite the company’s growth prospects. Analysis of Guardant Health’s valuation
  • Neutral Sentiment: Insider Terilyn Monroe sold 3,842 shares, reducing her holdings by 15.43%. The transaction was made under a pre-arranged Rule 10b5-1 plan, which may temper the significance of the sale as a signal about her outlook. Insider share sale report
Posted 1h agoAI Generated. May Contain Errors.

Guardant Health Latest News

What Guardant Health (GH)'s Raised Guidance Means For Shareholders
Guardant Health (GH) Stock Looks Richly Priced After Its Big Run
Guardant Health (NASDAQ:GH) Stock Jumps 4.8% - Still a Buy?
Guardant Health (NASDAQ:GH) Director Sells 116 Shares of Stock
Guardant Health prices $500M convertible notes offering
Guardant Health (NASDAQ:GH) Stock Price Target Cut by Piper Sandler
Stifel Nicolaus Remains a Buy on Guardant Health (GH)
Guardant Health (GH) Q3 2026 Earnings Call Transcript
What Guardant Health (GH) Said on Its Q3 Earnings Call
Guardant Health (NASDAQ:GH) Announces Earnings Results
Kevin Sayer Joins Guardant Health Board of Directors

Guardant Health Media Mentions By Week

Guardant Health Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GH
News Sentiment
▼
0.48

0.40
▲
Average
Healthcare
News Sentiment

Guardant Health News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GH Articles
This Week
▼
21

8
▲
GH Articles
Average Week

Guardant Health Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
8
+60%
Page Views
2,162
+3%
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Guardant Health dated 11/20/2026.
From Our Partners